Literature DB >> 32156377

Effect of okra fruit powder supplementation on metabolic syndrome and gut microbiota diversity in high fat diet-induced obese mice.

Jin Zhang1, Yan Zhao2, Daoyuan Ren3, Xingbin Yang4.   

Abstract

This study aimed to explore a novel strategy for dietary okra fruit powder (OFP) consumption on attenuation of non-alcohol fatty liver damage, lipid metabolic disorder and gut microbiota dysbiosis and associated mechanisms in high-fat diet (HFD)-induced obese mice. C57BL/6J mice were fed a normal diet and HFD feeds supplemented with or without OFP (2.5%, 5% and 10%, n = 10) for 12 weeks. The results showed that supplementation of OFP caused strong inhibition on HFD-caused high blood glucose, body weight gain and liver fat accumulation, as well as dyslipidemia involved in a dose-dependent modulation of hepatic FAS and CD36 expressions of obese mice. The hepatic LXR-α energy metabolism and PPAR-α pathway were also doubly activated by OFP to alleviate lipogenesis, obesity and metabolic syndrome. Malonaldehyde production was effectively antagonized, and glutathione peroxidase and superoxide dismutase activities were elevated by OFP supplementation in HFD-fed mice. OFP also significantly improved colonic SCFAs (acetic acid, propionic acid and butyrate acid) formation, especially for butyrate production via increasing the proportion of selected butyrate-producing bacteria. OFP also dramatically modified the gut microbial species at the family level with suppressing an increase in Proteobacteria, Actinobacteria and F/B ratio, and the decrease in Bacteroidetes caused by HFD. These findings support that dietary OFP consumption is a novel strategy to prevent obesity, metabolic syndrome and gut microbiota imbalance.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Gut microbiota; Lipid metabolic; Non-alcoholic fatty liver disease; Obesity; Okra fruit powder

Mesh:

Substances:

Year:  2019        PMID: 32156377     DOI: 10.1016/j.foodres.2019.108929

Source DB:  PubMed          Journal:  Food Res Int        ISSN: 0963-9969            Impact factor:   6.475


  5 in total

1.  Diosgenin Ameliorates Non-alcoholic Fatty Liver Disease by Modulating the Gut Microbiota and Related Lipid/Amino Acid Metabolism in High Fat Diet-Fed Rats.

Authors:  Yuan Zhou; Ruoqi Li; Yingyi Zheng; Meiying Song; Shanshan Zhang; Yunxia Sun; Mengying Wei; Xiang Fan
Journal:  Front Pharmacol       Date:  2022-04-25       Impact factor: 5.988

2.  Instant Dark Tea Alleviates Hyperlipidaemia in High-Fat Diet-Fed Rat: From Molecular Evidence to Redox Balance and Beyond.

Authors:  Si Qin; Zhilan He; Yuanjie Wu; Chaoxi Zeng; Zhibing Zheng; Haowei Zhang; Chenghao Lv; Yong Yuan; Haoren Wu; Jianhui Ye; Zhonghua Liu; Meng Shi
Journal:  Front Nutr       Date:  2022-02-03

3.  Coix Seed-Based Milk Fermented With Limosilactobacillus reuteri Improves Lipid Metabolism and Gut Microbiota in Mice Fed With a High-Fat Diet.

Authors:  Zhoujie Yang; Xiaoli Zhu; Anyan Wen; Jingqi Ran; Likang Qin; Yi Zhu
Journal:  Front Nutr       Date:  2022-07-12

4.  Intervention Effects of Okra Extract on Brain-Gut Peptides and Intestinal Microorganisms in Sleep Deprivation Rats.

Authors:  Jingru Wu; Mingxue Cao; Ming Hu; Yu Gong; Jianming Xue; Yilin Yang; Hairui Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-24       Impact factor: 2.650

Review 5.  Natural Products Targeting Liver X Receptors or Farnesoid X Receptor.

Authors:  Jianglian She; Tanwei Gu; Xiaoyan Pang; Yonghong Liu; Lan Tang; Xuefeng Zhou
Journal:  Front Pharmacol       Date:  2022-01-05       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.